-

62% of Healthcare Leaders Say Fragmented Data Is Blocking AI Scale, New Innovaccer Report Finds

Report reveals that while 63% of organizations now run AI in live workflows, data fragmentation is emerging as the top barrier to enterprise-scale impact across documentation, access, and revenue cycle operations.

SAN FRANCISCO--(BUSINESS WIRE)--Innovaccer Inc. a leading healthcare AI company, today released its State of Revenue Lifecycle in Healthcare 2026 report, based on a survey of 150 US healthcare professionals across 103 organizations. The peer-reviewed report, validated by Frost & Sullivan, finds that AI has firmly moved into live healthcare workflows, but fragmented data environments are now the primary constraint on scaling its impact.

The report examines how healthcare organizations are moving from AI experimentation to real-world deployment, while highlighting how fragmented data environments are increasingly limiting consistent, enterprise-scale impact across documentation, access, and revenue cycle operations.

Key findings include:

  • 63% report AI integrated into at least one workflow; 52% have expanded implementation across departments; 45% have established AI governance or ethics structures.
  • 62% cite fragmented data systems as the top barrier to scaling AI, ahead of staffing constraints, model transparency, and budget limitations.
  • Leaders report up to 40% reduction in documentation time, with the strongest gains when AI is embedded into core systems and aligned to coding and revenue workflows.
  • AI adoption concentrates first in high-volume workflows: workflow automation (52%), documentation support (46%), scheduling and access (41%), and revenue cycle automation (38%).
  • Most organizations remain early in maturity, with 70% self-classifying as early to mid-stage and 8% at enterprise scale.

“Financial and administrative leaders, like their clinical counterparts, are increasingly focused on working at the top of their expertise. AI and automation are being used to take on repetitive, routine tasks, freeing leaders to focus on complex financial transactions and high-impact issues such as preventable claim denials, prior authorization, and claim edits,” said Todd Nelson, Director, Partner Relationships and Chief Partnership Executive, Healthcare Financial Management Association (HFMA).

“What this report shows is simple: AI is already in production, but most organizations are trying to scale it on top of fragmented data,” said Abhinav Shashank, cofounder and CEO, Innovaccer. “The next 12 to 24 months will be defined by whether health systems standardize on a platform approach that unifies workflows and governance, or continue to accumulate disconnected tools that limit scale.”

The report frames 2026 as an architectural decision point: healthcare organizations will either consolidate around platform-based AI that unifies data, governance, and workflow execution, or continue adding point solutions that increase complexity, governance burden, and variability in outcomes.

“Healthcare is moving beyond the ‘shiny object’ phase of AI into a more mature focus on practical, measurable value. While pilots are transitioning into real operational use, adoption remains uneven, and achieving organization-wide scale will be essential for long-term impact,” said Benjamin Cassity, Director of Research and Strategy for Value-Based Care and AI, KLAS Research.

The State of Revenue Lifecycle in Healthcare 2026 report offers a comprehensive look at where healthcare AI is delivering measurable value today and the structural barriers organizations must address to scale impact.

Download the full report here.

About Innovaccer

Innovaccer activates the flow of healthcare data, empowering providers, payers, and government organizations to deliver intelligent and connected experiences that advance health outcomes. The Healthcare Intelligence Cloud equips every stakeholder in the patient journey to turn fragmented data into proactive, coordinated actions that elevate the quality of care and drive operational performance. Leading healthcare organizations like Orlando Health, Adventist Healthcare, and Banner Health trust Innovaccer to integrate a system of intelligence into their existing infrastructure, extending the human touch in healthcare. For more information, visit www.innovaccer.com.

Contacts

Press Contact:
Arushi Awasthi
Innovaccer Inc.
arushi.awasthi@innovaccer.com
415-562-2139

Innovaccer


Release Versions

Contacts

Press Contact:
Arushi Awasthi
Innovaccer Inc.
arushi.awasthi@innovaccer.com
415-562-2139

More News From Innovaccer

Innovaccer and Hospitalogy Release ‘Autonomous Healthcare’ Report, Revealing Key Margin and Operating Trends Across Major Health Systems

SAN FRANCISCO--(BUSINESS WIRE)--Innovaccer Inc., a leading healthcare AI company, and Hospitalogy, a healthcare research and intelligence firm, today announced the release of a new joint report, Autonomous Healthcare is Here: The 2026 Health System Paradigm Shift. The 60-page report provides an in-depth analysis of 2025 health system financial performance, operating strategies, and AI opportunities shaping the next era of US health systems. The research analyzes 15 of the country’s largest not-...

Community Care of North Carolina Partners with Innovaccer to Advance Value-Based Care Delivery for Independent Primary Care Providers in North Carolina

SAN FRANCISCO--(BUSINESS WIRE)--Innovaccer Inc., a leading healthcare AI company, today announced a five-year partnership with Community Care of North Carolina, Inc. (CCNC), the state’s largest and longest-running medical home system currently serving more than one million members. The partnership will leverage Innovaccer’s Healthcare Intelligence Cloud to enable CCNC care managers to identify and assist the appropriate patients at the optimal time and provide CCPN clinicians with powerful data...

Pharmacy Quality Solutions Announces Strategic Partnership with Pyrls to Transform Clinical Workflow for Pharmacists

SAN FRANCISCO--(BUSINESS WIRE)--Pharmacy Quality Solutions (PQS), an Innovaccer company and leader in pharmacy-payer performance technology, today announced a strategic partnership with Pyrls, the Y Combinator-backed clinical drug information platform trusted by over 50,000 clinicians and student clinicians. This collaboration integrates Pyrls' powerful drug information hub directly into EQUIPP Copilot, creating a seamless experience that supercharges clinical insights and empowers clinicians t...
Back to Newsroom